Back
Halozyme Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
HALO
Halozyme Therapeutics, Inc.
Last Price:
$64.49
Seasonality Move:
2.4%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.36 | Buy |
| 20-day SMA: | 64.33 | Buy |
| 50-day SMA: | 69.87 | Sell |
| 200-day SMA: | 67.31 | Sell |
| 8-day EMA: | 63.91 | Buy |
| 20-day EMA: | 64.96 | Sell |
| 50-day EMA: | 67.58 | Sell |
| 200-day EMA: | 66.64 | Sell |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | -209098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.71 - 67.91) | Sell |
| Bollinger Bands (100): | (64.52 - 74.08) | Sell |
Halozyme Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 64.49 while HALO 8-day simple moving average is 63.36, which is a Buy signal.
-
The stock price of HALO is 64.49 while Halozyme Therapeutics, Inc. 20-day SMA is 64.33, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 69.87 while HALO share price is 64.49, making it a Sell technically.
-
HALO stock price is 64.49 and Halozyme Therapeutics, Inc. 200-day simple moving average is 67.31, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
53
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a BuyThe current Halozyme Therapeutics, Inc. [HALO] share price is $64.49. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
7.5B
Price in USD:
64.49
Share Volume:
1.5M
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
82.22
52-Week Low:
47.50
Buy
53
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 64.49 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is not overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 64.49 while HALO 8-day exponential moving average is 63.91, which is a Buy signal.
-
The stock price of HALO is 64.49 while Halozyme Therapeutics, Inc. 20-day EMA is 64.96, which makes it a Sell.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 67.58 while HALO share price is 64.49, making it a Sell technically.
-
HALO stock price is 64.49 and Halozyme Therapeutics, Inc. 200-day simple moving average is 66.64, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.03 per share, an increase this year of $1.46 per share, and an increase next year of $1.83 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.64, suggesting Halozyme Therapeutics, Inc. is a Sell
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 44.98, which suggest Halozyme Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is (62.71 - 67.91), which suggest Halozyme Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is (64.52 - 74.08), which suggest Halozyme Therapeutics, Inc. is a Sell
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.